177Lu-DOTA-JR11 (Phase 0); Cycle 1 and Cycle 2 (cross-over) Clinical Trials

1 actively recruiting trial

Filter by location:

Other1 trial

Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotide

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.